Warning: This security is no longer trading.
Merck completes acquisition of ArQule
ArQule, Inc. (ARQL): Price and Financial Metrics
ARQL Price/Volume Stats
| Current price | $20.00 | 52-week high | $20.45 |
| Prev. close | $19.97 | 52-week low | $3.15 |
| Day low | $19.98 | Volume | 6,172,600 |
| Day high | $20.00 | Avg. volume | 5,269,080 |
| 50-day MA | $14.57 | Dividend yield | N/A |
| 200-day MA | $9.89 | Market Cap | 2.42B |
ARQL Stock Price Chart Interactive Chart >
ArQule, Inc. (ARQL) Company Bio
ArQule, Inc., a clinical-stage biotechnology company, researches and develops therapeutics for the treatment of cancer and rare diseases. The company was founded in 1993 and is based in Burlington, Massachusetts.
ARQL Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 144.20% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 620.58% |
Continue Researching ARQL
Want to see what other sources are saying about NA's financials and stock price? Try the links below:NA (ARQL) Stock Price | Nasdaq
NA (ARQL) Stock Quote, History and News - Yahoo Finance
NA (ARQL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...